UNASSIGNED: Included in this study were six SMMAT patients who received surgical treatment in our center between February 2013 and May 2022. Their clinical data and outcomes were retrospectively analyzed to gain a better understanding of SMMAT. In addition, ten cases from the literature focusing on SMMAT were also reviewed.
UNASSIGNED: Surgery was performed successfully, and the associated symptoms were relieved significantly in all patients postoperatively. The mean follow-up duration was 26.2 (range 3-55) months. Two patients died of tumor recurrence 12 and 48 months after operation respectively. The other four patients were alive at the last follow-up.
UNASSIGNED: The prognosis of SMMAT is usually poor. Preoperative embolization and early surgical radical resection can offer satisfactory clinical outcomes. The patient\'s health status, preoperative neurological function, tumor location and the resection mode are potential prognostic factors of SMMAT.
UNASSIGNED:本研究包括6名在2013年2月至2022年5月期间在我们中心接受手术治疗的SMMAT患者。
未经证实:手术成功,
未经证实:SMMAT的预后通常较差。